Role of tight junctions in cell proliferation and cancer

Progress in Histochemistry and Cytochemistry

Volumn 42, Issue 1, 2007, Pages 1-57

  González Mariscal, Lorenza ^a   Lechuga, Susana ^a   Garay, Erika ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Cancer; Claudins; Occludin; Oncoproteins; PDZ; Tight junctions; ZO 1

Indexed keywords

ADAPTOR PROTEIN; BETA CATENIN; CLAUDIN; GAMMA INTERFERON; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; JUNCTIONAL ADHESION MOLECULE A; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; OCCLUDIN; PDZ PROTEIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ADENOVIRUS; ARTICLE; CANCER; CELL ADHESION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; MESENCHYME CELL; MOUSE; NONHUMAN; RETROVIRUS; SIMIAN VIRUS 40; TIGHT JUNCTION; TUMOR SUPPRESSOR GENE; WART VIRUS;

EID: 34248157567     PISSN: 00796336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.proghi.2007.01.001     Document Type: Article

References (379)

1. Agarwal R., D'Souza T., and Morin P.J. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65 (2005) 7378-7385
2. Aijaz S., D'Atri F., Citi S., Balda M.S., and Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell 8 (2005) 777-786
3. Al Moustafa A.E., Alaoui-Jamali M.A., Batist G., Hernandez-Perez M., Serruya C., Alpert L., et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21 (2002) 2634-2640
4. Alexandre M.D., Lu Q., and Chen Y.H. Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells. J Cell Sci 118 (2005) 2683-2693
5. Alroy J. Ultrastructure of canine urinary bladder carcinoma. Vet Pathol 16 (1979) 693-701
6. Anderson J.M., and Cereijido M. Evolution of ideas on the tight junction. In: Cereijido M., and Anderson J.M. (Eds). Tight junctions (2001), CRC Press, Boca Raton, FL 1-18
7. Andreeva A.Y., Krause E., Muller E.C., Blasig I.E., and Utepbergenov D.I. Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 276 (2001) 38480-38486
8. Asada M., Irie K., Morimoto K., Yamada A., Ikeda W., Takeuchi M., et al. ADIP, a novel Afadin- and alpha-actinin-binding protein localized at cell-cell adherens junctions. J Biol Chem 278 (2003) 4103-4111
9. Aung P.P., Mitani Y., Sanada Y., Nakayama H., Matsusaki K., and Yasui W. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virch Arch 448 (2006) 428-434
10. Aurrand-Lions M.A., Duncan L., Du P.L., and Imhof B.A. Cloning of JAM-2 and JAM-3: an emerging junctional adhesion molecular family?. Curr Top Microbiol Immunol 251 (2000) 91-98
11. Aurrand-Lions M., Duncan L., Ballestrem C., and Imhof B.A. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem 276 (2001) 2733-2741
12. Aznar S., Fernandez-Valeron P., Espina C., and Lacal J.C. Rho GTPases: potential candidates for anticancer therapy. Cancer Lett 206 (2004) 181-191
13. Baas A.F., Kuipers J., van der Wel N.N., Batlle E., Koerten H.K., Peters P.J., et al. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116 (2004) 457-466
14. Bakiri L., Lallemand D., Bossy-Wetzel E., and Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19 (2000) 2056-2068
15. Balda M.S., and Anderson J.M. Two classes of tight junctions are revealed by ZO-1 isoforms. Am J Physiol 264 (1993) C918-C924
16. Balda M.S., and Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 19 (2000) 2024-2033
17. Balda M.S., Anderson J.M., and Matter K. The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain. FEBS Lett 399 (1996) 326-332
18. Balda M.S., Whitney J.A., Flores C., Gonzalez S., Cereijido M., and Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134 (1996) 1031-1049
19. Balda M.S., Garrett M.D., and Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 160 (2003) 423-432
20. Ball E.E., Hayward D.C., Saint R., and Miller D.J. A simple plan - cnidarians and the origins of developmental mechanisms. Nat Rev Genet 5 (2004) 567-577
21. Barnard J.A., and Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 4 (1993) 495-501
22. Barnard J.A., Beauchamp R.D., Russell W.E., Dubois R.N., and Coffey R.J. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108 (1995) 564-580
23. Bazzoni G., Martinez-Estrada O.M., Orsenigo F., Cordenonsi M., Citi S., and Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275 (2000) 20520-20526
24. Becker W., and Joost H.G. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucl Acid Res Mol Biol 62 (1999) 1-17
25. Beisel C., Imhof A., Greene J., Kremmer E., and Sauer F. Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1. Nature 419 (2002) 857-862
26. Benais-Pont G., Punn A., Flores-Maldonado C., Eckert J., Raposo G., Fleming T.P., et al. Identification of a tight junction-associated guanine nucleotide exchange factor that activates Rho and regulates paracellular permeability. J Cell Biol 160 (2003) 729-740
27. Betanzos A., Huerta M., Lopez-Bayghen E., Azuara E., Amerena J., and Gonzalez-Mariscal L. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 292 (2004) 51-66
28. Bilder D., Li M., and Perrimon N. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 289 (2000) 113-116
29. Bishop W.P., and Wen J.T. Regulation of Caco-2 cell proliferation by basolateral membrane epidermal growth factor receptors. Am J Physiol 267 (1994) G892-G900
30. Boettner B., Govek E.E., Cross J., and Van Aelst L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc Natl Acad Sci USA 97 (2000) 9064-9069
31. Bonner J.A., De Los S.J., Waksal H.W., Needle M.N., Trummel H.Q., and Raisch K.P. Epidermal growth factor receptor as a therapeutic target in head and neck cancer. Semin Radiat Oncol 12 (2002) 11-20
32. Bordin M., D'Atri F., Guillemot L., and Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res 2 (2004) 692-701
33. Boussioutas A., Li H., Liu J., Waring P., Lade S., Holloway A.J., et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 63 (2003) 2569-2577
34. Braithwaite A.W., Cheetham B.F., Li P., Parish C.R., Waldron-Stevens L.K., and Bellett A.J. Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J Virol 45 (1983) 192-199
35. Brieher W.M., and Gumbiner B.M. Regulation of C-cadherin function during activin induced morphogenesis of Xenopus animal caps. J Cell Biol 126 (1994) 519-527
36. Buchert M., Poon C., King J.A., Baechi T., D'Abaco G., Hollande F., et al. AF6/s-afadin is a dual residency protein and localizes to a novel subnuclear compartment. J Cell Physiol (2006)
37. Busch C., Hanssen T.A., Wagener C., and OBrink B. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol 33 (2002) 290-298
38. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman J.G., et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57 (1997) 4997-5000
39. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2 (2000) 76-83
40. Carbone M., Pass H.I., Miele L., and Bocchetta M. New developments about the association of SV40 with human mesothelioma. Oncogene 22 (2003) 5173-5180
41. Carrozzino F., Soulie P., Huber D., Mensi N., Orci L., Cano A., et al. Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol 289 (2005) C1002-C1014
42. Cereijido M., Contreras R.G., and Shoshani L. Cell adhesion, polarity, and epithelia in the dawn of metazoans. Physiol Rev 84 (2004) 1229-1262
43. Chen Y.H., Lu Q., Goodenough D.A., and Jeansonne B. Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell 13 (2002) 1227-1237
44. Chen S.P., Zhou B., Willis B.C., Sandoval A.J., Liebler J.M., Kim K.J., et al. Effects of transdifferentiation and EGF on claudin isoform expression in alveolar epithelial cells. J Appl Physiol 98 (2005) 322-328
45. Cheung S.T., Leung K.L., Ip Y.C., Chen X., Fong D.Y., Ng I.O., et al. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11 (2005) 551-556
46. Chinnadurai G. Modulation of oncogenic transformation by the human adenovirus E1A C-terminal region. Curr Top Microbiol Immunol 273 (2004) 139-161
47. Chlenski A., Ketels K.V., Tsao M.S., Talamonti M.S., Anderson M.R., Oyasu R., et al. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. Int J Cancer 82 (1999) 137-144
48. Chlenski A., Ketels K.V., Korovaitseva G.I., Talamonti M.S., Oyasu R., and Scarpelli D.G. Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues. Biochim Biophys Acta 1493 (2000) 319-324
49. Cicchetti P., Mayer B.J., Thiel G., and Baltimore D. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257 (1992) 803-806
50. Ciolofan C., Li X.B., Olson C., Kamasawa N., Gebhardt B.R., Yasumura T., et al. Association of connexin36 and zonula occludens-1 with zonula occludens-2 and the transcription factor zonula occludens-1-associated nucleic acid-binding protein at neuronal gap junctions in rodent retina. Neuroscience 140 (2006) 433-451
51. Citi S., and Cordenonsi M. The molecular base of the structure, function and regulation of tight junctions. In: Garrod D.R., North A.J., and Chidgey M.A.J. (Eds). Adhesive interactions of cells (1999), JAI Press Inc., Greenwich 203-233
52. Citi S., Sabanay H., Kendrick-Jones J., and Geiger B. Cingulin: characterization and localization. J Cell Sci 93 Pt 1 (1989) 107-122
53. Claude P., and Goodenough D.A. Fracture faces of zonulae occludentes from "tight" and "leaky" epithelia. J Cell Biol 58 (1973) 390-400
54. Cohen C.J., Shieh J.T., Pickles R.J., Okegawa T., Hsieh J.T., and Bergelson J.M. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98 (2001) 15191-15196
55. Conway Morris S. The fossil record and the early evolution of the Metazoa. Nature 361 (1993) 219-225
56. Cordenonsi M., D'Atri F., Hammar E., Parry D.A., Kendrick-Jones J., Shore D., et al. Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol 147 (1999) 1569-1582
57. Cunningham S.A., Rodriguez J.M., Arrate M.P., Tran T.M., and Brock T.A. JAM2 interacts with alpha4beta1. Facilitation by JAM3. J Biol Chem 277 (2002) 27589-27592
58. Cunningham S.C., Kamangar F., Kim M.P., Hammoud S., Haque R., Iacobuzio-Donahue C.A., et al. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev 15 (2006) 281-287
59. D'Atri F., and Citi S. Cingulin interacts with F-actin in vitro. FEBS Lett 507 (2001) 21-24
60. Dalgarno D.C., Botfield M.C., and Rickles R.J. SH3 domains and drug design: ligands, structure, and biological function. Biopolymers 43 (1997) 383-400
61. Danielpour D. Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta. J Cell Sci 112 Pt 2 (1999) 169-179
62. Davies R.J., Joseph R., Asbun H., and Sedwitz M. Detection of the cancer-prone colon, using transepithelial impedance analysis. Arch Surg 124 (1989) 480-484
63. de Oliveira S.S., de Oliveira I.M., De Souza W., and Morgado-Diaz J.A. Claudins upregulation in human colorectal cancer. FEBS Lett 579 (2005) 6179-6185
64. Deguchi M., Hata Y., Takeuchi M., Ide N., Hirao K., Yao I., et al. BEGAIN (brain-enriched guanylate kinase-associated protein), a novel neuronal PSD-95/SAP90-binding protein. J Biol Chem 273 (1998) 26269-26272
65. Del Maschio A., De Luigi A., Martin-Padura I., Brockhaus M., Bartfai T., Fruscella P., et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 190 (1999) 1351-1356
66. Dhawan P., Singh A.B., Deane N.G., No Y., Shiou S.R., Schmidt C., et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115 (2005) 1765-1776
67. Di Cristofano A., Pesce B., Cordon-Cardo C., and Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat Genet 19 (1998) 348-355
68. DIAMOND J.M. The mechanism of solute transport by the gall-bladder. J Physiol 161 (1962) 474-502
69. DIAMOND J.M. The mechanism of water transport by the gall-bladder. J Physiol 161 (1962) 503-527
70. DIAMOND J.M., and Wright E.M. Biological membranes: the physical basis of ion and nonelectrolyte selectivity. Annu Rev Physiol 31 (1969) 581-646
71. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 (1998) 262-267
72. Dragsten P.R., Blumenthal R., and Handler J.S. Membrane asymmetry in epithelia: is the tight junction a barrier to diffusion in the plasma membrane?. Nature 294 (1981) 718-722
73. Ebnet K., Schulz C.U., Meyer zu Brickwedde M.K., Pendl G.G., and Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 275 (2000) 27979-27988
74. Ebnet K., Suzuki A., Horikoshi Y., Hirose T., Meyer zu Brickwedde M.K., Ohno S., et al. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 20 (2001) 3738-3748
75. Ebnet K., Aurrand-Lions M., Kuhn A., Kiefer F., Butz S., Zander K., et al. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J Cell Sci 116 (2003) 3879-3891
76. Elias P.M., and Friend D.S. The permeability barrier in mammalian epidermis. J Cell Biol 65 (1975) 180-191
77. Escaffit F., Boudreau F., and Beaulieu J.F. Differential expression of claudin-2 along the human intestine: Implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol 203 (2005) 15-26
78. Etienne-Manneville S., and Hall A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106 (2001) 489-498
79. Fang C.M., and Xu Y.H. Down-regulated expression of atypical PKC-binding domain deleted asip isoforms in human hepatocellular carcinomas. Cell Res 11 (2001) 223-229
80. Fanning A.S., Jameson B.J., Jesaitis L.A., and Anderson J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273 (1998) 29745-29753
81. FARQUHAR M.G., and PALADE G.E. Junctional complexes in various epithelia. J Cell Biol 17 (1963) 375-412
82. Fischer R.S., and Quinlan M.P. The C terminus of E1A regulates tumor progression and epithelial cell differentiation. Virology 249 (1998) 427-439
83. Fish S.M., Proujansky R., and Reenstra W.W. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 45 (1999) 191-198
84. Fleming T.P., Sheth B., Thomas F., Fesenko I., and Eckert J. Developmental assembly of the tight junctions. In: Cereijido M., and Anderson J.M. (Eds). Tight junctions (2001), CRC Press, Boca Raton, FL 285-303
85. Fluge O., Haugen D.R., Lillehaug J.R., and Varhaug J.E. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue. World J Surg 25 (2001) 623-631
86. Frankel P., Aronheim A., Kavanagh E., Balda M.S., Matter K., Bunney T.D., et al. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J 24 (2005) 54-62
87. Frisch S.M., and Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 9 (1997) 701-706
88. Fu X.D., and Maniatis T. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature 343 (1990) 437-441
89. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., Tsukita S., et al. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 127 (1994) 1617-1626
90. Furuse M., Hata M., Furuse K., Yoshida Y., Haratake A., Sugitani Y., et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156 (2002) 1099-1111
91. Gatza M.L., Watt J.C., and Marriott S.J. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22 (2003) 5141-5149
92. Giepmans B.N., and Moolenaar W.H. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 8 (1998) 931-934
93. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 (2003) 1-24
94. Gilles C., Polette M., Mestdagt M., Nawrocki-Raby B., Ruggeri P., Birembaut P., et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63 (2003) 2658-2664
95. Glaunsinger B.A., Lee S.S., Thomas M., Banks L., and Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19 (2000) 5270-5280
96. Glaunsinger B.A., Weiss R.S., Lee S.S., and Javier R. Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. EMBO J 20 (2001) 5578-5586
97. Glaven J.A., Whitehead I.P., Nomanbhoy T., Kay R., and Cerione R.A. Lfc and Lsc oncoproteins represent two new guanine nucleotide exchange factors for the Rho GTP-binding protein. J Biol Chem 271 (1996) 27374-27381
98. Gonzales A.J., Goldsworthy T.L., and Fox T.R. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes. Carcinogenesis 19 (1998) 1093-1102
99. Gonzalez-Mariscal L., Namorado M.C., Martin D., Luna J., Alarcon L., Islas S., et al. Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. Kidney Int 57 (2000) 2386-2402
100. Gonzalez-Mariscal L., Ponce A., Alarcon L., and Jaramillo B.E. The tight junction protein ZO-2 has several functional nuclear export signals. Exp Cell Res 312 (2006) 3323-3335
101. Gottardi C.J., Arpin M., Fanning A.S., and Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA 93 (1996) 10779-10784
102. Graham K.A., and Buick R.N. Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor. J Cell Physiol 136 (1988) 63-71
103. Guillemont L., and Citi S. Cingulin, a cytoskeletal associated protein of the tight junction. In: Gonzalez-Mariscal L. (Ed). Tight junctions (2006), Landes Bioscience and Springer, Georgetown and New York 54-63
104. Gumbiner B.M. Regulation of cadherin adhesive activity. J Cell Biol 148 (2000) 399-404
105. Gyorffy H., Holczbauer A., Nagy P., Szabo Z., Kupcsulik P., Paska C., et al. Claudin expression in Barrett's esophagus and adenocarcinoma. Virch Arch 447 (2005) 961-968
106. Hamazaki Y., Itoh M., Sasaki H., Furuse M., and Tsukita S. Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277 (2002) 455-461
107. Hanada N., Makino K., Koga H., Morisaki T., Kuwahara H., Masuko N., et al. NE-dlg, a mammalian homolog of Drosophila dlg tumor suppressor, induces growth suppression and impairment of cell adhesion: possible involvement of down-regulation of beta-catenin by NE-dlg expression. Int J Cancer 86 (2000) 480-488
108. Haskins J., Gu L., Wittchen E.S., Hibbard J., and Stevenson B.R. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 141 (1998) 199-208
109. Hay E.D. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154 (1995) 8-20
110. Hayashi J., Kajino K., Umeda T., Takano S., Arakawa Y., Kudo M., et al. Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis. Int J Oncol 21 (2002) 847-850
111. Hirabayashi S., Tajima M., Yao I., Nishimura W., Mori H., and Hata Y. JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol Cell Biol 23 (2003) 4267-4282
112. Hoevel T., Macek R., Mundigl O., Swisshelm K., and Kubbies M. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 191 (2002) 60-68
113. Hoevel T., Macek R., Swisshelm K., and Kubbies M. Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 108 (2004) 374-383
114. Hofmann I., Schnolzer M., Kaufmann I., and Franke W.W. Symplekin, a constitutive protein of karyo- and cytoplasmic particles involved in mRNA biogenesis in Xenopus laevis oocytes. Mol Biol Cell 13 (2002) 1665-1676
115. Hollander D. Crohn's disease - a permeability disorder of the tight junction?. Gut 29 (1988) 1621-1624
116. Honda H., Pazin M.J., Ji H., Wernyj R.P., and Morin P.J. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 281 (2006) 21433-21444
117. Hoover K.B., Liao S.Y., and Bryant P.J. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 153 (1998) 1767-1773
118. Horne-Badovinac S., Lin D., Waldron S., Schwarz M., Mbamalu G., Pawson T., et al. Positional cloning of heart and soul reveals multiple roles for PKC lambda in zebrafish organogenesis. Curr Biol 11 (2001) 1492-1502
119. Hough C.D., Woods D.F., Park S., and Bryant P.J. Organizing a functional junctional complex requires specific domains of the Drosophila MAGUK Discs large. Genes Dev 11 (1997) 3242-3253
120. Hough C.D., Sherman-Baust C.A., Pizer E.S., Montz F.J., Im D.D., Rosenshein N.B., et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60 (2000) 6281-6287
121. Humbert P., Russell S., and Richardson H. Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer. Bioessays 25 (2003) 542-553
122. Hurd T.W., Gao L., Roh M.H., Macara I.G., and Margolis B. Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol 5 (2003) 137-142
123. Ikenouchi J., Matsuda M., Furuse M., and Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 116 (2003) 1959-1967
124. Ikenouchi J., Furuse M., Furuse K., Sasaki H., Tsukita S., and Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171 (2005) 939-945
125. Ishidate T., Matsumine A., Toyoshima K., and Akiyama T. The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene 19 (2000) 365-372
126. Islas S., Vega J., Ponce L., and Gonzalez-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 274 (2002) 138-148
127. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., and Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147 (1999) 1351-1363
128. Itoh M., Morita K., and Tsukita S. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J Biol Chem 274 (1999) 5981-5986
129. Itoh M., Sasaki H., Furuse M., Ozaki H., Kita T., and Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 154 (2001) 491-497
130. Jaramillo B.E., Ponce A., Moreno J., Betanzos A., Huerta M., Lopez-Bayghen E., et al. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res 297 (2004) 247-258
131. Jin M., Barron E., He S., Ryan S.J., and Hinton D.R. Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. Invest Ophthalmol Vis Sci 43 (2002) 2782-2790
132. Johnson-Leger C.A., Aurrand-Lions M., Beltraminelli N., Fasel N., and Imhof B.A. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood 100 (2002) 2479-2486
133. Jorgensen P.E., Rasmussen T.N., Skov O.P., Raaberg L., Seier P.S., and Nexo E. Renal uptake and excretion of epidermal growth factor from plasma in the rat. Regul Pept 28 (1990) 273-281
134. Kaihara T., Kawamata H., Imura J., Fujii S., Kitajima K., Omotehara F., et al. Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1. Cancer Sci 94 (2003) 166-172
135. Kaihara T., Kusaka T., Nishi M., Kawamata H., Imura J., Kitajima K., et al. Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis. J Exp Clin Cancer Res 22 (2003) 117-123
136. Kale G., Naren A.P., Sheth P., and Rao R.K. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun 302 (2003) 324-329
137. Katoh M., and Katoh M. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11 (2003) 683-689
138. Kausalya P.J., Reichert M., and Hunziker W. Connexin45 directly binds to ZO-1 and localizes to the tight junction region in epithelial MDCK cells. FEBS Lett 505 (2001) 92-96
139. Kausalya P.J., Phua D.C., and Hunziker W. Association of ARVCF with zonula occludens (ZO)-1 and ZO-2: binding to PDZ-domain proteins and cell-cell adhesion regulate plasma membrane and nuclear localization of ARVCF. Mol Biol Cell 15 (2004) 5503-5515
140. Kavanagh E., Tsapara A., and Matter K.B.M.S. Tight junctions and regulation of epithelial cell proliferation and gene expression. In: Gonzalez-Mariscal L. (Ed). Tight junctions (2006), Landes Bioscience and Springer Science, Georgetown, New York 99-115
141. Keon B.H., Schafer S., Kuhn C., Grund C., and Franke W.W. Symplekin, a novel type of tight junction plaque protein. J Cell Biol 134 (1996) 1003-1018
142. Khoury H., Dankort D.L., Sadekova S., Naujokas M.A., Muller W.J., and Park M. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene 20 (2001) 788-799
143. Khoury H., Naujokas M.A., Zuo D., Sangwan V., Frigault M.M., Petkiewicz S., et al. HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion. Mol Biol Cell 16 (2005) 550-561
144. Kim E., Naisbitt S., Hsueh Y.P., Rao A., Rothschild A., Craig A.M., et al. GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol 136 (1997) 669-678
145. Kimura S., Hara Y., Pineau T., Fernandez-Salguero P., Fox C.H., Ward J.M., et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10 (1996) 60-69
146. Kimura Y., Shiozaki H., Hirao M., Maeno Y., Doki Y., Inoue M., et al. Expression of occludin, tight-junction-associated protein, in human digestive tract. Am J Pathol 151 (1997) 45-54
147. Kistner U., Garner C.C., and Linial M. Nucleotide binding by the synapse associated protein SAP90. FEBS Lett 359 (1995) 159-163
148. Kiuchi-Saishin Y., Gotoh S., Furuse M., Takasuga A., Tano Y., and Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13 (2002) 875-886
149. Kleeff J., Shi X., Bode H.P., Hoover K., Shrikhande S., Bryant P.J., et al. Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer. Pancreas 23 (2001) 259-265
150. Knust E., Tepass U., and Wodarz A. crumbs and stardust, two genes of Drosophila required for the development of epithelial cell polarity. Dev Suppl 261-68 (1993)
151. Kohno K., Izumi H., Uchiumi T., Ashizuka M., and Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25 (2003) 691-698
152. Kojima T., Sawada N., Chiba H., Kokai Y., Yamamoto M., Urban M., et al. Induction of tight junctions in human connexin 32 (hCx32)-transfected mouse hepatocytes: connexin 32 interacts with occludin. Biochem Biophys Res Commun 266 (1999) 222-229
153. Kojima T., Kokai Y., Chiba H., Yamamoto M., Mochizuki Y., and Sawada N. Cx32 but not Cx26 is associated with tight junctions in primary cultures of rat hepatocytes. Exp Cell Res 263 (2001) 193-201
154. Kominsky S.L., Argani P., Korz D., Evron E., Raman V., Garrett E., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22 (2003) 2021-2033
155. Kominsky S.L., Vali M., Korz D., Gabig T.G., Weitzman S.A., Argani P., et al. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 164 (2004) 1627-1633
156. Kostrewa D., Brockhaus M., D'Arcy A., Dale G.E., Nelboeck P., Schmid G., et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 20 (2001) 4391-4398
157. Kotelevets L., van Hengel J., Bruyneel E., Mareel M., van Roy F., and Chastre E. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 19 (2005) 115-117
158. Kramer F., White K., Kubbies M., Swisshelm K., and Weber B.H. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107 (2000) 249-256
159. Kurihara H., Anderson J.M., and FARQUHAR M.G. Diversity among tight junctions in rat kidney: glomerular slit diaphragms and endothelial junctions express only one isoform of the tight junction protein ZO-1. Proc Natl Acad Sci USA 89 (1992) 7075-7079
160. Kuwahara H., Araki N., Makino K., Masuko N., Honda S., Kaibuchi K., et al. A novel NE-dlg/SAP102-associated protein, p51-nedasin, related to the amidohydrolase superfamily, interferes with the association between NE-dlg/SAP102 and N-methyl-d-aspartate receptor. J Biol Chem 274 (1999) 32204-32214
161. Lamagna C., Hodivala-Dilke K.M., Imhof B.A., and Aurrand-Lions M. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res 65 (2005) 5703-5710
162. Lane N. Tight junctions in invertebrates. In: Cereijido M., and Anderson J.M. (Eds). Tight junctions (2001), CRC, Boca Raton, FL 39-59
163. Langbein L., Grund C., Kuhn C., Praetzel S., Kartenbeck J., Brandner J.M., et al. Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 81 (2002) 419-435
164. Langbein L., Pape U.F., Grund C., Kuhn C., Praetzel S., Moll I., et al. Tight junction-related structures in the absence of a lumen: occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas. Eur J Cell Biol 82 (2003) 385-400
165. Latorre I.J., Roh M.H., Frese K.K., Weiss R.S., Margolis B., and Javier R.T. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci 118 (2005) 4283-4293
166. Lechner F., Sahrbacher U., Suter T., Frei K., Brockhaus M., Koedel U., et al. Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection. J Infect Dis 182 (2000) 978-982
167. Lee S.S., Glaunsinger B., Mantovani F., Banks L., and Javier R.T. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 74 (2000) 9680-9693
168. Lee S.K., Moon J., Park S.W., Song S.Y., Chung J.B., and Kang J.K. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma. Oncol Rep 13 (2005) 193-199
169. Lemmers C., Medina E., Delgrossi M.H., Michel D., Arsanto J.P., and Le Bivic A. hINADl/PATJ, a homolog of discs lost, interacts with crumbs and localizes to tight junctions in human epithelial cells. J Biol Chem 277 (2002) 25408-25415
170. Letessier A., Garrido-Urbani S., Ginestier C., Fournier G., Esterni B., Monville F., et al. Correlated break at PARK2/FRA6E and loss of AF-6/afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006)
171. Li D., and Mrsny R.J. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J Cell Biol 148 (2000) 791-800
172. Li W.Y., Huey C.L., and Yu A.S. Expression of claudin-7 and -8 along the mouse nephron. Am J Physiol Renal Physiol 286 (2004) F1063-F1071
173. Li X., Olson C., Lu S., Kamasawa N., Yasumura T., Rash J.E., et al. Neuronal connexin36 association with zonula occludens-1 protein (ZO-1) in mouse brain and interaction with the first PDZ domain of ZO-1. Eur J Neurosci 19 (2004) 2132-2146
174. Liotta L.A., and Kohn E. Anoikis: cancer and the homeless cell. Nature 430 (2004) 973-974
175. Litvak D.A., Evers B.M., Hwang K.O., Hellmich M.R., Ko T.C., and Townsend Jr. C.M. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 124 (1998) 161-169
176. Liu Y., Nusrat A., Schnell F.J., Reaves T.A., Walsh S., Pochet M., et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113 Pt 13 (2000) 2363-2374
177. Lodi C., Szabo E., Holczbauer A., Batmunkh E., Szijarto A., Kupcsulik P., et al. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol 19 (2006) 460-469
178. Long H., Crean C.D., Lee W.H., Cummings O.W., and Gabig T.G. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61 (2001) 7878-7881
179. Loor G., Zhang S.J., Zhang P., Toomey N.L., and Lee M.Y. Identification of DNA replication and cell cycle proteins that interact with PCNA. Nucl Acids Res 25 (1997) 5041-5046
180. Lopez-Bayghen E., Jaramillo B.E., Huerta M., Betanzos A., and Gonzalez-Mariscal L. Tight junction proteins that make round trips to the nucleus. In: Gonzalez-Mariscal L. (Ed). Tight junctions (2006), Landes Bioscience and Springer Science, Georgetown, New York 76-100
181. Ma T.Y., Iwamoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286 (2004) G367-G376
182. Macias M.J., Wiesner S., and Sudol M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett 513 (2002) 30-37
183. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273 (1998) 13375-13378
184. Maier S., Reich E., Martin R., Bachem M., Altug V., Hautmann R.E., et al. Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines. Int J Cancer 88 (2000) 245-251
185. Makino K., Kuwahara H., Masuko N., Nishiyama Y., Morisaki T., Sasaki J., et al. Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Oncogene 14 (1997) 2425-2433
186. Malergue F., Galland F., Martin F., Mansuelle P., Aurrand-Lions M., and Naquet P. A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol Immunol 35 (1998) 1111-1119
187. Mandai K., Nakanishi H., Satoh A., Obaishi H., Wada M., Nishioka H., et al. Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol 139 (1997) 517-528
188. Mandai K., Nakanishi H., Satoh A., Takahashi K., Satoh K., Nishioka H., et al. Ponsin/SH3P12: an L-afadin- and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions. J Cell Biol 144 (1999) 1001-1017
189. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96 (1999) 1603-1608
190. Marte B.M., and Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22 (1997) 355-358
191. Martin T.A., Watkins G., Mansel R.E., and Jiang W.G. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 40 (2004) 2717-2725
192. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142 (1998) 117-127
193. Martinez-Palomo A. Ultrastructural modifications of intercellular junctions in some epithelial tumors. Lab Invest 22 (1970) 605-614
194. Masuko N., Makino K., Kuwahara H., Fukunaga K., Sudo T., Araki N., et al. Interaction of NE-dlg/SAP102, a neuronal and endocrine tissue-specific membrane-associated guanylate kinase protein, with calmodulin and PSD-95/SAP90. A possible regulatory role in molecular clustering at synaptic sites. J Biol Chem 274 (1999) 5782-5790
195. Matter K., and Balda M.S. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4 (2003) 225-236
196. Mayr D., Kanitz V., Amann G., Engel J., Burges A., Lohrs U., et al. HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays. Histopathology 48 (2006) 149-156
197. Mazo A.M., Huang D.H., Mozer B.A., and Dawid I.B. The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proc Natl Acad Sci USA 87 (1990) 2112-2116
198. McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., et al. Occludin is a functional component of the tight junction. J Cell Sci 109 Pt 9 (1996) 2287-2298
199. McGee A.W., and Bredt D.S. Identification of an intramolecular interaction between the SH3 and guanylate kinase domains of PSD-95. J Biol Chem 274 (1999) 17431-17436
200. McGee A.W., Dakoji S.R., Olsen O., Bredt D.S., Lim W.A., and Prehoda K.E. Structure of the SH3-guanylate kinase module from PSD-95 suggests a mechanism for regulated assembly of MAGUK scaffolding proteins. Mol Cell 8 (2001) 1291-1301
201. McKnight S.L. McBindall - a better name for CCAAT/enhancer binding proteins?. Cell 107 (2001) 259-261
202. Medici D., Hay E.D., and Goodenough D.A. Cooperation between Snail and LEF-1 Transcription factors is essential for TGF-{beta}1-induced epithelial-mesenchymal transition. Mol Biol Cell (2006)
203. Mehlen P., and Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 6 (2006) 449-458
204. Metais J.Y., Navarro C., Santoni M.J., Audebert S., and Borg J.P. hScrib interacts with ZO-2 at the cell-cell junctions of epithelial cells. FEBS Lett 579 (2005) 3725-3730
205. Michl P., Buchholz M., Rolke M., Kunsch S., Lohr M., McClane B., et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121 (2001) 678-684
206. Michl P., Barth C., Buchholz M., Lerch M.M., Rolke M., Holzmann K.H., et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63 (2003) 6265-6271
207. Missiaglia E., Blaveri E., Terris B., Wang Y.H., Costello E., Neoptolemos J.P., et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112 (2004) 100-112
208. Mitic L., and Van Itallie C.M. Occludin an claudins: transmembrane proteins of the tight junction. In: Cereijido M., and Anderson J.M. (Eds). Tight junction (2001), CRC Press, Boca Raton, FL 213-230
209. Mizuarai S., Yamanaka K., and Kotani H. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells. Cancer Res 66 (2006) 6319-6326
210. Montesano R., Friend D.S., Perrelet A., and Orci L. In vivo assembly of tight junctions in fetal rat liver. J Cell Biol 67 (1975) 310-319
211. Montgomery E., Mamelak A.J., Gibson M., Maitra A., Sheikh S., Amr S.S., et al. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol 14 (2006) 24-30
212. Moorthamer M., Zumstein-Mecker S., and Chaudhuri B. DNA binding protein dbpA binds Cdk5 and inhibits its activity. FEBS Lett 446 (1999) 343-350
213. Moreno J.H. Blockage of gallbladder tight junction cation-selective channels by 2,4,6-triaminopyrimidinium (TAP). J Gen Physiol 66 (1975) 97-115
214. Moreno J.H. Routes of nonelectrolyte permeability in gallbladder. Effects of 2,4,6-triaminopyrimidinium (TAP). J Gen Physiol 66 (1975) 117-128
215. Morita K., Tsukita S., and Miyachi Y. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol 151 (2004) 328-334
216. Mukohara T., Kudoh S., Yamauchi S., Kimura T., Yoshimura N., Kanazawa H., et al. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC). Lung Cancer 41 (2003) 123-130
217. Muller D., Kausalya P.J., Claverie-Martin F., Meij I.C., Eggert P., Garcia-Nieto V., et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 73 (2003) 1293-1301
218. Muller S.L., Portwich M., Schmidt A., Utepbergenov D.I., Huber O., Blasig I.E., et al. The tight junction protein occludin and the adherens junction protein alpha-catenin share a common interaction mechanism with ZO-1. J Biol Chem 280 (2005) 3747-3756
219. Mullin J.M., and McGinn M.T. Epidermal growth factor-induced mitogenesis in kidney epithelial cells (LLC-PK1). Cancer Res 48 (1988) 4886-4891
220. Mullin J.M., and Snock K.V. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50 (1990) 2172-2176
221. Mungre S., Enderle K., Turk B., Porras A., Wu Y.Q., Mumby M.C., et al. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J Virol 68 (1994) 1675-1681
222. Muto S., Furuya H., Tabei K., and Asano Y. Site and mechanism of action of epidermal growth factor in rabbit cortical collecting duct. Am J Physiol 260 (1991) F163-F169
223. Nakagawa S., and Huibregtse J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol 20 (2000) 8244-8253
224. Nakagawa S., Yano T., Nakagawa K., Takizawa S., Suzuki Y., Yasugi T., et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. Br J Cancer 90 (2004) 194-199
225. Nakamura T., Blechman J., Tada S., Rozovskaia T., Itoyama T., Bullrich F., et al. huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proc Natl Acad Sci USA 97 (2000) 7284-7289
226. Nakatsura T., Senju S., Yamada K., Jotsuka T., Ogawa M., and Nishimura Y. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem Biophys Res Commun 281 (2001) 936-944
227. National Cancer Institute and US National Institutes of Health. SEER cancer statistics review 1975-2003. 2003. Ref Type: Data File.
228. Navarro C., Nola S., Audebert S., Santoni M.J., Arsanto J.P., Ginestier C., et al. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 24 (2005) 4330-4339
229. Nayler O., Stratling W., Bourquin J.P., Stagljar I., Lindemann L., Jasper H., et al. SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucl Acids Res 26 (1998) 3542-3549
230. Nielsen P.A., Baruch A., Shestopalov V.I., Giepmans B.N., Dunia I., Benedetti E.L., et al. Lens connexins alpha3Cx46 and alpha8Cx50 interact with zonula occludens protein-1 (ZO-1). Mol Biol Cell 14 (2003) 2470-2481
231. Nieto M.A. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3 (2002) 155-166
232. Niimi T., Nagashima K., Ward J.M., Minoo P., Zimonjic D.B., Popescu N.C., et al. claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol Cell Biol 21 (2001) 7380-7390
233. Nix S.L., Chishti A.H., Anderson J.M., and Walther Z. hCASK and hDlg associate in epithelia, and their src homology 3 and guanylate kinase domains participate in both intramolecular and intermolecular interactions. J Biol Chem 275 (2000) 41192-41200
234. Nunbhakdi-Craig V., Machleidt T., Ogris E., Bellotto D., White III C.L., and Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 158 (2002) 967-978
235. Nunbhakdi-Craig V., Craig L., Machleidt T., and Sontag E. Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J Virol 77 (2003) 2807-2818
236. Nusrat A., Parkos C.A., Bacarra A.E., Godowski P.J., Delp-Archer C., Rosen E.M., et al. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest 93 (1994) 2056-2065
237. Nusrat A., Chen J.A., Foley C.S., Liang T.W., Tom J., Cromwell M., et al. The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem 275 (2000) 29816-29822
238. Oesterreich S., Allredl D.C., Mohsin S.K., Zhang Q., Wong H., Lee A.V., et al. High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer. Br J Cancer 84 (2001) 493-498
239. Ohashi M., Sakurai M., Higuchi M., Mori N., Fukushi M., Oie M., et al. Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZ domain protein, MAGI-3. Virology 320 (2004) 52-62
240. Ohkubo T., and Ozawa M. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117 (2004) 1675-1685
241. Oku N., Sasabe E., Ueta E., Yamamoto T., and Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 66 (2006) 5251-5257
242. Ooshio T., Irie K., Morimoto K., Fukuhara A., Imai T., and Takai Y. Involvement of LMO7 in the association of two cell-cell adhesion molecules, nectin and E-cadherin, through afadin and alpha-actinin in epithelial cells. J Biol Chem 279 (2004) 31365-31373
243. Osanai M., Murata M., Nishikiori N., Chiba H., Kojima T., and Sawada N. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 66 (2006) 9125-9133
244. Ostermann G., Weber K.S., Zernecke A., Schroder A., and Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3 (2002) 151-158
245. Pallas D.C., Weller W., Jaspers S., Miller T.B., Lane W.S., and Roberts T.M. The third subunit of protein phosphatase 2A (PP2A), a 55-kilodalton protein which is apparently substituted for by T antigens in complexes with the 36- and 63-kilodalton PP2A subunits, bears little resemblance to T antigens. J Virol 66 (1992) 886-893
246. Palmeri D., van Zante A., Huang C.C., Hemmerich S., and Rosen S.D. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem 275 (2000) 19139-19145
247. Pasdar M., Li Z., Marreli M., Nguyen B.T., Park M., and Wong K. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules. Cell Growth Differ 8 (1997) 451-462
248. Patrick D.M., Leone A.K., Shellenberger J.J., Dudowicz K.A., and King J.M. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 6 (2006) 2
249. Pegram M.D., Pauletti G., and Slamon D.J. HER-2/neu as a predictive marker of response to breast cancer therapy. Breast Cancer Res Treat 52 (1998) 65-77
250. Peinado H., Portillo F., and Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48 (2004) 365-375
251. Peng B.H., Lee J.C., and Campbell G.A. In vitro protein complex formation with cytoskeleton-anchoring domain of occludin identified by limited proteolysis. J Biol Chem 278 (2003) 49644-49651
252. Peralta S.A., Mullin J.M., Knudsen K.A., and Marano C.W. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol 270 (1996) F869-F879
253. Planchon S.M., Martins C.A., Guerrant R.L., and Roche J.K. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 153 (1994) 5730-5739
254. Planchon S., Fiocchi C., Takafuji V., and Roche J.K. Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists. J Cell Physiol 181 (1999) 55-66
255. Polette M., Gilles C., Nawrocki-Raby B., Lohi J., Hunziker W., Foidart J.M., et al. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 65 (2005) 7691-7698
256. Pollack A.L., Runyan R.B., and Mostov K.E. Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis. Dev Biol 204 (1998) 64-79
257. Potempa S., and Ridley A.J. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 9 (1998) 2185-2200
258. Powell D.W. Barrier function of epithelia. Am J Physiol 241 (1981) G275-G288
259. Prasad R., Gu Y., Alder H., Nakamura T., Canaani O., Saito H., et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 53 (1993) 5624-5628
260. Prota A.E., Campbell J.A., Schelling P., Forrest J.C., Watson M.J., Peters T.R., et al. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci USA 100 (2003) 5366-5371
261. Purves W.K., Sadava D., Orians G.H., and Heller H.C. Animal development: from genes to organism. In: Purves W.K., Sadava D., Orians G.H., and Heller H.C. (Eds). Life the science of biology (2004), Sinauer Associates and W.H. Freeman and Company, USA 408-428
262. Purves W.K., Sadava D., Orians G.H., and Heller H.C. Animal origins and the evolution of body plans. In: Purves W.K., Sadava D., Orians G.H., and Heller H.C. (Eds). Life the science of biology (2004), Sinauer Associates and W.H. Freeman and Company, USA 619-640
263. Rangel L.B., Agarwal R., D'Souza T., Pizer E.S., Alo P.L., Lancaster W.D., et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9 (2003) 2567-2575
264. Rasheed B.K., Stenzel T.T., McLendon R.E., Parsons R., Friedman A.H., Friedman H.S., et al. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57 (1997) 4187-4190
265. Rea S., Eisenhaber F., O'Carroll D., Strahl B.D., Sun Z.W., Schmid M., et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406 (2000) 593-599
266. Reichert M., Muller T., and Hunziker W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J Biol Chem 275 (2000) 9492-9500
267. Resnick M.B., Gavilanez M., Newton E., Konkin T., Bhattacharya B., Britt D.E., et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 36 (2005) 886-892
268. Reyes J.L., Lamas M., Martin D., del Carmen N.M., Islas S., Luna J., et al. The renal segmental distribution of claudins changes with development. Kidney Int 62 (2002) 476-487
269. Robenek H., Schopper C., Fasske E., Fetting R., and Themann H. Structure and function of the junctional complement of spontaneous and transplanted murine mammary carcinomas. J Submicrosc Cytol 13 (1981) 347-363
270. Roh M.H., Liu C.J., Laurinec S., and Margolis B. The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions. J Biol Chem 277 (2002) 27501-27509
271. Roh M.H., Makarova O., Liu C.J., Shin K., Lee S., Laurinec S., et al. The Maguk protein, Pals1, functions as an adapter, linking mammalian homologues of Crumbs and Discs Lost. J Cell Biol 157 (2002) 161-172
272. Roh M.H., Fan S., Liu C.J., and Margolis B. The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells. J Cell Sci 116 (2003) 2895-2906
273. Ruediger R., Roeckel D., Fait J., Bergqvist A., Magnusson G., and Walter G. Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol 12 (1992) 4872-4882
274. Ryeom S.W., Paul D., and Goodenough D.A. Truncation mutants of the tight junction protein ZO-1 disrupt corneal epithelial cell morphology. Mol Biol Cell 11 (2000) 1687-1696
275. Sahai E., and Marshall C.J. RHO-GTPases and cancer. Nat Rev Cancer 2 (2002) 133-142
276. Sahlas D.J., Milankov K., Park P.C., and De Boni U. Distribution of snRNPs, splicing factor SC-35 and actin in interphase nuclei: immunocytochemical evidence for differential distribution during changes in functional states. J Cell Sci 105 Pt 2 (1993) 347-357
277. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11 (2000) 4131-4142
278. Sakaguchi T., Gu X., Golden H.M., Suh E., Rhoads D.B., and Reinecker H.C. Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem 277 (2002) 21361-21370
279. Santin A.D., Cane S., Bellone S., Palmieri M., Siegel E.R., Thomas M., et al. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer Res 65 (2005) 4334-4342
280. Santoni M.J., Pontarotti P., Birnbaum D., and Borg J.P. The LAP family: a phylogenetic point of view. Trends Genet 18 (2002) 494-497
281. Santoso S., Orlova V.V., Song K., Sachs U.J., Andrei-Selmer C.L., and Chavakis T. The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem 280 (2005) 36326-36333
282. Satoh K., Yanai H., Senda T., Kohu K., Nakamura T., Okumura N., et al. DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. Genes Cells 2 (1997) 415-424
283. Schaeper U., Boyd J.M., Verma S., Uhlmann E., Subramanian T., and Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci USA 92 (1995) 10467-10471
284. Scheving L.A., Shiurba R.A., Nguyen T.D., and Gray G.M. Epidermal growth factor receptor of the intestinal enterocyte. Localization to laterobasal but not brush border membrane. J Biol Chem 264 (1989) 1735-1741
285. Schmidt A., Utepbergenov D.I., Mueller S.L., Beyermann M., Schneider-Mergener J., Krause G., et al. Occludin binds to the SH3-hinge-GuK unit of Zonula occludens protein 1: potential mechanism of tight junction regulation. Cell Mol Life Sci 61 (2004) 1354-1365
286. Schmitz H., Fromm M., Bentzel C.J., Scholz P., Detjen K., Mankertz J., et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112 Pt 1 (1999) 137-146
287. Schreiber M., Kolbus A., Piu F., Szabowski A., Mohle-Steinlein U., Tian J., et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 13 (1999) 607-619
288. Schulzke J.D., and Fromm M. Tight junctions in intestinal inflamation. In: Cereijido M., and Anderson J.M. (Eds). Tight junctions (2001), CRC Press, Boca Raton, FL 553-571
289. Selli C., Amorosi A., Vona G., Sestini R., Travaglini F., Bartoletti R., et al. Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. J Urol 158 (1997) 245-247
290. Shah K., and Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 103 (1976) 1-12
291. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
292. Shaw S.K., Perkins B.N., Lim Y.C., Liu Y., Nusrat A., Schnell F.J., et al. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow. Am J Pathol 159 (2001) 2281-2291
293. Shearn A. The ash-1, ash-2 and trithorax genes of Drosophila melanogaster are functionally related. Genetics 121 (1989) 517-525
294. Sheth B., Fesenko I., Collins J.E., Moran B., Wild A.E., Anderson J.M., et al. Tight junction assembly during mouse blastocyst formation is regulated by late expression of ZO-1 alpha+ isoform. Development 124 (1997) 2027-2037
295. Sheth B., Moran B., Anderson J.M., and Fleming T.P. Post-translational control of occludin membrane assembly in mouse trophectoderm: a mechanism to regulate timing of tight junction biogenesis and blastocyst formation. Development 127 (2000) 831-840
296. Shimizu T., Izumi H., Oga A., Furumoto H., Murakami T., Ofuji R., et al. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 202 (2001) 203-206
297. Simon D.B., Lu Y., Choate K.A., Velazquez H., Al Sabban E., Praga M., et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285 (1999) 103-106
298. Singh A.B., and Harris R.C. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem 279 (2004) 3543-3552
299. Smales C., Ellis M., Baumber R., Hussain N., Desmond H., and Staddon J.M. Occludin phosphorylation: identification of an occludin kinase in brain and cell extracts as CK2. FEBS Lett 545 (2003) 161-166
300. Smalley K.S., Brafford P., Haass N.K., Brandner J.M., Brown E., and Herlyn M. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 166 (2005) 1541-1554
301. Sobel G., Szabo I., Paska C., Kiss A., Kovalszky I., Kadar A., et al. Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia. Pathol Oncol Res 11 (2005) 26-31
302. Soler A.P., Miller R.D., Laughlin K.V., Carp N.Z., Klurfeld D.M., and Mullin J.M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20 (1999) 1425-1431
303. Sommers C.L., Heckford S.E., Skerker J.M., Worland P., Torri J.A., Thompson E.W., et al. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52 (1992) 5190-5197
304. Sommers C.L., Byers S.W., Thompson E.W., Torri J.A., and Gelmann E.P. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31 (1994) 325-335
305. Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., et al. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275 (1997) 73-77
306. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal 13 (2001) 7-16
307. Sontag E., Fedorov S., Kamibayashi C., Robbins D., Cobb M., and Mumby M. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75 (1993) 887-897
308. Soubeyran P., Andre F., Lissitzky J.C., Mallo G.V., Moucadel V., Roccabianca M., et al. Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology 117 (1999) 1326-1338
309. Sourisseau T., Georgiadis A., Tsapara A., Ali R.R., Pestell R., Matter K., et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 26 (2006) 2387-2398
310. Subauste M.C., Nalbant P., Adamson E.D., and Hahn K.M. Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. J Biol Chem 280 (2005) 5676-5681
311. Sudol M., and Hunter T. New wrinkles for an old domain. Cell 103 (2000) 1001-1004
312. Suh E., and Traber P.G. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16 (1996) 619-625
313. Swift J.G., Mukherjee T.M., and Rowland R. Intercellular junctions in hepatocellular carcinoma. J Submicrosc Cytol 15 (1983) 799-810
314. Tabibzadeh S., Kong Q.F., Kapur S., Satyaswaroop P.G., and Aktories K. Tumour necrosis factor-alpha-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/beta-catenin and disassembly of actin filaments. Hum Reprod 10 (1995) 994-1004
315. Takagaki Y., and Manley J.L. Complex protein interactions within the human polyadenylation machinery identify a novel component. Mol Cell Biol 20 (2000) 1515-1525
316. Takai Y., and Nakanishi H. Nectin and afadin: novel organizers of intercellular junctions. J Cell Sci 116 (2003) 17-27
317. Takai E., Tan X., Tamori Y., Hirota M., Egami H., and Ogawa M. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells. Int J Oncol 27 (2005) 645-651
318. Takeuchi M., Hata Y., Hirao K., Toyoda A., Irie M., and Takai Y. SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. J Biol Chem 272 (1997) 11943-11951
319. Tan X., Egami H., Ishikawa S., Nakagawa M., Ishiko T., Kamohara H., et al. Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer. Int J Oncol 25 (2004) 1303-1309
320. Tan X., Egami H., Ishikawa S., Kurizaki T., Hirota M., and Ogawa M. Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells. Dig Dis Sci 50 (2005) 1402-1409
321. Tashiro H., Blazes M.S., Wu R., Cho K.R., Bose S., Wang S.I., et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57 (1997) 3935-3940
322. Tedelind S., Ericson L.E., Karlsson J.O., and Nilsson M. Interferon-gamma down-regulates claudin-1 and impairs the epithelial barrier function in primary cultured human thyrocytes. Eur J Endocrinol 149 (2003) 215-221
323. Tepass U., and Knust E. Crumbs and stardust act in a genetic pathway that controls the organization of epithelia in Drosophila melanogaster. Dev Biol 159 (1993) 311-326
324. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7 (2006) 131-142
325. Thomas U., Phannavong B., Muller B., Garner C.C., and Gundelfinger E.D. Functional expression of rat synapse-associated proteins SAP97 and SAP102 in Drosophila dlg-1 mutants: effects on tumor suppression and synaptic bouton structure. Mech Dev 62 (1997) 161-174
326. Thomas M., Glaunsinger B., Pim D., Javier R., and Banks L. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 20 (2001) 5431-5439
327. Thomas M., Laura R., Hepner K., Guccione E., Sawyers C., Lasky L., et al. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21 (2002) 5088-5096
328. Thomas F.C., Sheth B., Eckert J.J., Bazzoni G., Dejana E., and Fleming T.P. Contribution of JAM-1 to epithelial differentiation and tight-junction biogenesis in the mouse preimplantation embryo. J Cell Sci 117 (2004) 5599-5608
329. Tobioka H., Isomura H., Kokai Y., and Sawada N. Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J Pathol 198 (2002) 207-212
330. Tobioka H., Isomura H., Kokai Y., Tokunaga Y., Yamaguchi J., and Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 35 (2004) 159-164
331. Tobioka H., Tokunaga Y., Isomura H., Kokai Y., Yamaguchi J., and Sawada N. Expression of occludin, a tight-junction-associated protein, in human lung carcinomas. Virch Arch 445 (2004) 472-476
332. Tokes A.M., Kulka J., Paku S., Mathe M., Paska C., Lodi C., et al. The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract 201 (2005) 537-544
333. Tokes A.M., Kulka J., Paku S., Szik A., Paska C., Novak P.K., et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7 (2005) R296-R305
334. Traweger A., Fang D., Liu Y.C., Stelzhammer W., Krizbai I.A., Fresser F., et al. The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch. J Biol Chem 277 (2002) 10201-10208
335. Traweger A., Fuchs R., Krizbai I.A., Weiger T.M., Bauer H.C., and Bauer H. The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J Biol Chem 278 (2003) 2692-2700
336. Tripoulas N., LaJeunesse D., Gildea J., and Shearn A. The Drosophila ash1 gene product, which is localized at specific sites on polytene chromosomes, contains a SET domain and a PHD finger. Genetics 143 (1996) 913-928
337. Troyer K.L., and Lee D.C. Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 6 (2001) 7-21
338. Tsukita S., and Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149 (2000) 13-16
339. Tsukita S., and Furuse M. Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14 (2002) 531-536
340. Umeda K., Ikenouchi J., Katahira-Tayama S., Furuse K., Sasaki H., Nakayama M., et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 126 (2006) 741-754
341. Underwood J.L., Murphy C.G., Chen J., Franse-Carman L., Wood I., Epstein D.L., et al. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am J Physiol 277 (1999) C330-C342
342. Usami Y., Chiba H., Nakayama F., Ueda J., Matsuda Y., Sawada N., et al. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 37 (2006) 569-577
343. Van Itallie C.M., and Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol 68 (2006) 403-429
344. Van Itallie C., Rahner C., and Anderson J.M. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107 (2001) 1319-1327
345. Van Itallie C.M., Fanning A.S., and Anderson J.M. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 285 (2003) F1078-F1084
346. van Meer G., and Simons K. The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. EMBO J 5 (1986) 1455-1464
347. van Meer G., Gumbiner B., and Simons K. The tight junction does not allow lipid molecules to diffuse from one epithelial cell to the next. Nature 322 (1986) 639-641
348. Verri E., Guglielmini P., Puntoni M., Perdelli L., Papadia A., Lorenzi P., et al. HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study. Oncology 68 (2005) 154-161
349. Vietor I., Bader T., Paiha K., and Huber L.A. Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Rep 2 (2001) 306-312
350. Vilchez R.A., Kozinetz C.A., Arrington A.S., Madden C.R., and Butel J.S. Simian virus 40 in human cancers. Am J Med 114 (2003) 675-684
351. Wang H., Iakova P., Wilde M., Welm A., Goode T., Roesler W.J., et al. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 8 (2001) 817-828
352. Wang Z., Mandell K.J., Parkos C.A., Mrsny R.J., and Nusrat A. The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene 24 (2005) 4412-4420
353. Wilcox E.R., Burton Q.L., Naz S., Riazuddin S., Smith T.N., Ploplis B., et al. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 104 (2001) 165-172
354. Williams A.F., and Barclay A.N. The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol 6 (1988) 381-405
355. Willott E., Balda M.S., Fanning A.S., Jameson B., Van Itallie C., and Anderson J.M. The tight junction protein ZO-1 is homologous to the Drosophila discs - large tumor suppressor protein of septate junctions. Proc Natl Acad Sci USA 90 (1993) 7834-7838
356. Wittchen E.S., Haskins J., and Stevenson B.R. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 274 (1999) 35179-35185
357. Wodarz A., Hinz U., Engelbert M., and Knust E. Expression of crumbs confers apical character on plasma membrane domains of ectodermal epithelia of Drosophila. Cell 82 (1995) 67-76
358. Wojciak-Stothard B., Entwistle A., Garg R., and Ridley A.J. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol 176 (1998) 150-165
359. Woods D.F., and Bryant P.J. Molecular cloning of the lethal(1)discs large-1 oncogene of Drosophila. Dev Biol 134 (1989) 222-235
360. Woods D.F., and Bryant P.J. The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions. Cell 66 (1991) 451-464
361. Woods D.F., Hough C., Peel D., Callaini G., and Bryant P.J. Dlg protein is required for junction structure, cell polarity, and proliferation control in Drosophila epithelia. J Cell Biol 134 (1996) 1469-1482
362. Woods D.F., Wu J.W., and Bryant P.J. Localization of proteins to the apico-lateral junctions of Drosophila epithelia. Dev Genet 20 (1997) 111-118
363. Wu X., Hepner K., Castelino-Prabhu S., Do D., Kaye M.B., Yuan X.J., et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 97 (2000) 4233-4238
364. Wu Y., Dowbenko D., Spencer S., Laura R., Lee J., Gu Q., et al. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem 275 (2000) 21477-21485
365. Xiong Y., Zhang H., and Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71 (1992) 505-514
366. Xiong Y., Zhang H., and Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7 (1993) 1572-1583
367. Yamada A., Fujita N., Sato T., Okamoto R., Ooshio T., Hirota T., et al. Requirement of nectin, but not cadherin, for formation of claudin-based tight junctions in annexin II-knockdown MDCK cells. Oncogene 25 (2006) 5085-5102
368. Yamamoto T., Harada N., Kano K., Taya S., Canaani E., Matsuura Y., et al. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 139 (1997) 785-795
369. Yin F., Qiao T., Shi Y., Xiao B., Chen B., Miao J., et al. [In situ hybridization of tight junction molecule occludin mRNA in gastric cancer]. Zhonghua Zhong Liu Za Zhi 24 (2002) 557-560
370. Yokoyama S., Tachibana K., Nakanishi H., Yamamoto Y., Irie K., Mandai K., et al. alpha-catenin-independent recruitment of ZO-1 to nectin-based cell-cell adhesion sites through afadin. Mol Biol Cell 12 (2001) 1595-1609
371. Yoshida K., Kanaoka S., Takai T., Uezato T., Miura N., Kajimura M., et al. EGF rapidly translocates tight junction proteins from the cytoplasm to the cell-cell contact via protein kinase C activation in TMK-1 gastric cancer cells. Exp Cell Res 309 (2005) 397-409
372. Youakim A., and Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 276 (1999) G1279-G1288
373. Yu A.S., Enck A.H., Lencer W.I., and Schneeberger E.E. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem 278 (2003) 17350-17359
374. Yuan B., Li C., Kimura S., Engelhardt R.T., Smith B.R., and Minoo P. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn 217 (2000) 180-190
375. Zegers M.M., O'Brien L.E., Yu W., Datta A., and Mostov K.E. Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol 13 (2003) 169-176
376. Zen K., Babbin B.A., Liu Y., Whelan J.B., Nusrat A., and Parkos C.A. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell 15 (2004) 3926-3937
377. Zhang G.J., Tsuda H., Adachi I., Fukutomi T., Yamamoto H., and Hirohashi S. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins. Jpn J Clin Oncol 27 (1997) 371-377
378. Zhang Z., Smith M.M., and Mymryk J.S. Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Mol Biol Cell 12 (2001) 699-710
379. Zhu Y., Brannstrom M., Janson P.O., and Sundfeldt K. Differences in expression patterns of the tight junction proteins,claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer 118 (2006) 1884-1891